News

Successful 2022 ESOT ACADEMIA course in Rome

By: Simon Knight | Posted on 11th April 2022

After cancellation last year due to the COVID pandemic, we were very pleased to be back in Rome last week for the 2022 ESOT ACADEMIA course. The annual course, organised by ESOT and run in collaboration with the CET, aims to teach professional skills including oral and online presentation, systematic review and meta-analysis and statistics […]

Read more

May 2018 Transplant Trial Watch now available

By: Simon Knight | Posted on 2nd May 2018

The May 2018 edition of the Transplant Trial Watch is now available online. This month’s studies include the impact of allograft nephrectomy on subsequent transplants, the mid- and long-term risks of living kidney donation, and the use of transcatheter arterial embolisation in patients with APKD prior to transplant.

Read more

ACADEMIA – a new course from ESOT, Vienna May 2018

By: Simon Knight | Posted on 9th January 2018

The European Society in Organ Transplantation and the Centre for Evidence in Transplantation have teamed up to create a new course for future leaders in transplantation.  Replacing the Evidence in Transplantation (EVIT) course and European Transplant Fellows Workshop (ETFW), this new course aims to teach: Academic skills – research, critical appraisal, evidence based medicine, systematic […]

Read more

December 2016 Transplant Trial Watch now online

By: Simon Knight | Posted on 1st December 2016

The December 2016 edition of the Transplant Trial Watch is now available. This month, articles include a trial of fibrin glue to prevent complications after renal transplantation, a meta-analysis of renal outcomes in live kidney donors and the risk of biliary complications following live donor liver transplantation. It also includes an analysis of the HTA […]

Read more

October 2016 Transplant Trial Watch now available

By: Simon Knight | Posted on 3rd October 2016

The October 2016 edition of the Transplant Trial Watch is now online. This month includes a trial of Eculizumab for chronic antibody mediated rejection, a review of the impact of multiple renal arteries in renal transplantation and a trial of antibiotic treatment of ex-vivo perfused lungs.

Read more

September 2016 Transplant Trial Watch now available

By: Simon Knight | Posted on 5th September 2016

The September 2016 edition of the Transplant Trial Watch is now available. This month’s studies include include the perils of late CNI withdrawal, CNI to mTORi conversion in Liver Transplant recipients and computer-based home education.

Read more

July 2016 Transplant Trial Watch now available

By: Simon Knight | Posted on 1st July 2016

The July 2016 edition of the Transplant Trial Watch is now available. This month, trials include long-term outcomes from BENEFIT-EXT, treatment of asymptomatic bacteriuria in renal transplant recipients and and in depth analysis of the VICTOR trial.

Read more

June 2016 Transplant Trial Watch is now online

By: Simon Knight | Posted on 3rd June 2016

The June 2016 Transplant Trial Watch is now available. This month, the trial watch includes systematic reviews of quality of life reporting in renal transplant trials and extended criteria donors, as well as an analysis of wound complications with everolimus following cardiac transplantation.

Read more

May 2016 Transplant Trial Watch now available

By: Simon Knight | Posted on 29th April 2016

The May 2016 Transplant Trial Watch is now available online and via our app for iPhone, iPad and Android. This months new trials include long-term follow-up from the Spare the Nephron trial, methods for promoting organ donation and mobile medical apps for encouraging sun protection behaviour.

Read more

February 2016 Transplant Trial Watch now online

By: Simon Knight | Posted on 2nd February 2016

The February 2016 edition of the Transplant Trial Watch is now available. This month’s ten new trials include a comparison of parathyroidectomy and cinacalcet for management of post-transplant hyperparathyroidism, heamoxygenase-1 upregulation in renal transplant recipients and sirolimus for liver transplant recipients with hepatocellular carcinoma.

Read more

Next Page »